Semaglutide is a GLP-1 receptor agonist used to treat type 2 diabetes and obesity, with FDA-approved formulations like Ozempic (for diabetes) and Wegovy (for weight loss)
Its theoretical mechanisms and observed effects in animal studies have led to interest in applications for companion animals, though veterinary use remains investigational
Consequently, dose titration is slow and dependent on AEs, and common recommendations like reduction on food quantity or high fat or spicy food is always suggested (151, 154, 158) Also, some hypotheses might suggest that GLP-1 stimulation can affect taste perception, as it has been reported by the FDA Adverse Event Reporting System (FAERS)
Related Reading Semaglutide For Weight Loss 2 Diabetes Weight Loss Drug Semaglutide Tablets For Weight Loss Semaglutide Pills For Weight Loss Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
.png)
